DM Clinical Research Celebrates 20 Years of Expanding Clinical Trial Access

DM Clinical Research marks its 20th anniversary, highlighting its growth into a leading network of over 35 sites and its impact on advancing clinical research through patient access and innovation.

Chicago Metrowire Staff
Healthcare
DM Clinical Research Celebrates 20 Years of Expanding Clinical Trial Access

DM Clinical Research is commemorating its 20th anniversary, a milestone that underscores its evolution from a visionary startup into one of the nation's leading integrated clinical research networks. Founded in 2006 with a mission to make clinical trials more accessible and patient-centered, the organization has since expanded its footprint to over 35 research sites, serving a patient population of 1.97 million across 32 therapeutic areas.

Over the past two decades, DM Clinical has enrolled more than 35,000 patients in clinical trials, contributing to the development of therapies that have improved lives globally. The company's growth reflects its commitment to operational excellence, diverse patient access, and strong enrollment performance, which have made it a preferred partner for pharmaceutical, biotechnology, and contract research organizations.

"Reaching 20 years is incredibly meaningful to me," said Mohammad Millwala, Founder and CEO. "When I think about DM Clinical Research, I think first about the people—the employees who have poured their talent and heart into this organization, and the patients who have trusted us to be part of their healthcare journey. We've experienced so much growth and change over the past two decades, but what has never changed is our commitment to our patients and to doing meaningful work that makes a difference."

The company's achievements have been recognized with industry honors, including the SPRIA Award for vaccine enrollment, the Excellence in Patient Centricity Award, ViE's Best Clinical Trial Network Award, and the SCRS Site Spark Award. In 2025, Millwala was honored with the SCRS Christine K. Pierre Site Impact Award, acknowledging his leadership in advancing clinical research.

As part of its mission to expand access, DM Clinical continues to grow its presence in underserved communities, ensuring more patients can participate in life-changing trials. Its integrated operating model combines local physician relationships with centralized infrastructure, delivering quality and speed for sponsors.

The 20th anniversary theme, "Champions of Clinical Research: 20 Years of Impact," reflects the teamwork and dedication that have fueled growth. Guided by core values—Think Forward, Find a Way, Create Impact, Own It, and Win Together—the company is investing in new technologies and expanding its therapeutic expertise to accelerate the delivery of innovative therapies.

Looking ahead, DM Clinical plans further expansion into new communities and increased investment in technologies that improve patient access. As Millwala noted, "The next chapter for DM Clinical is about expanding access to research, embracing new technologies, and ensuring more patients have the opportunity to participate in clinical trials that can change lives."

Blockchain Registration

QR Code for Blockchain Registration